Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis
Javier Rangel-Moreno, … , Moises Selman, Troy D. Randall
Javier Rangel-Moreno, … , Moises Selman, Troy D. Randall
Published December 1, 2006
Citation Information: J Clin Invest. 2006;116(12):3183-3194. https://doi.org/10.1172/JCI28756.
View: Text | PDF
Research Article Pulmonology

Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis

  • Text
  • PDF
Abstract

Bronchus-associated lymphoid tissue (BALT) was originally described as a mucosal lymphoid organ in the lungs of some species. However, while the lungs of naive mice and humans typically lack BALT, pulmonary infection in mice leads to the development of inducible BALT (iBALT), which is located in peribronchial, perivascular, and interstitial areas throughout the lung. Here we investigated whether iBALT forms in patients with a variety of interstitial lung diseases. We show that while iBALT can be found in the lungs of patients suffering from multiple diseases, well-developed iBALT is most prevalent in patients with pulmonary complications of RA and Sjögren syndrome. In these patients, iBALT consisted of numerous B cell follicles containing germinal centers and follicular dendritic cells. A loosely defined T cell area surrounded the B cell follicles while lymphatics and high endothelial venules were found at the B cell/T cell interface. Increased expression of lymphoid-organizing chemokines, such as CXCL13 and CCL21, as well as molecules involved in the immunopathology of RA, such as B cell–activating factor of the TNF family (BAFF), ICOS ligand, and lymphotoxin, correlated with more well-developed iBALT. Finally, the presence of iBALT correlated with tissue damage in the lungs of RA patients, suggesting that iBALT participates in local RA pathogenesis.

Authors

Javier Rangel-Moreno, Louise Hartson, Carmen Navarro, Miguel Gaxiola, Moises Selman, Troy D. Randall

×

Figure 5

Expression of genes that correlate with lymphoid tissue organization in lung biopsies that contain iBALT.

Options: View larger image (or click on image) Download as PowerPoint
Expression of genes that correlate with lymphoid tissue organization in ...
DNA-free RNA was extracted from normal lung (NL) or lung biopsies from patients who had pulmonary diseases associated with RA. The 4 samples selected exhibited a range of phenotypes from those with low levels of iBALT (RA2 and SS1), higher levels of iBALT (RA4), and the highest levels of iBALT (RA7). Extracted mRNA was reverse transcribed and used in a quantitative PCR array to determine relative mRNA expression patterns. The mRNA levels of each gene in each sample were first normalized to the expression of 18S RNA in that sample and then normalized to the expression of that gene in normal lung. The expression of selected chemokine mRNAs showed strong increases (A), moderate increases (B), or no increases (C) relative to mRNA expression in normal lung. The expression of selected cytokine mRNAs was also compared with that in normal lung (D). The levels of 18S RNA in the 4 patient samples were independently analyzed (in duplicate) by semiquantitative PCR and shown to be similar in all samples (bottom panel of C).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts